_×
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Antibody > Rabbit PAb Antibody > IL-13 / ALRH Antibody (Antigen Affinity Purified)

IL-13 / ALRH Antibody (Antigen Affinity Purified) (Cytokine) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
10369-RP02
  YES          

IL13 / ALRH Antibody ( Antigen Affinity Purified ) Datasheet

  Order or Inquire for IL13 / ALRH Antibody product Quality antibodies Antibody production services
  Detection limit is 2 ng/lane in WB
  Detection limit is 0.039 ng/well in ELISA
 

IL13 / ALRH Antibody Product Information

Immunogen :

Recombinant Human IL13 protein (Catalog#10369-H01H)

Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
Ig Type :

Rabbit IgG

Formulation : 0.2 μm filtered solution in PBS with 5% trehalose
Preparation :

Produced in rabbits immunized with purified, recombinant Human IL13 / ALRH (rh IL13 / ALRH; Catalog#10369-H01H; AAK53823.1; Gly 21-Asn 132). IL13 / ALRH specific IgG was purified by Human IL13 / ALRH affinity chromatography.

IL13 / ALRH Antibody Usage Guide

Specificity :

Human IL13 / ALRH

Western blot : This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human IL13 in WB. Using a DAB detection system, the detection limit for Human IL13 is approximately 0.5 ng/lane under non-reducing conditions and 2 ng/lane under reducing conditions.
Direct ELISA : This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human IL13 . The detection limit for Human IL13 is approximately 0.039 ng/well.
Storage : This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

IL13 / ALRH Antibody Related Products & Topics

Related Areas:

Cancer>>Angiogenesis>>Cytokines/Chemokines in Angiogenesis>>IL-13

Immunology>>Adaptive Immunity>>B Cell>>IL-13

Immunology>>Adaptive Immunity>>T Cell>>Helper T Cell>>IL-13

Immunology>>Cytokine & Receptor>>Interleukin & Receptor>>Other>>IL-13

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
IL-13/ALRH Human IL-13/ALRH/Fc Protein, Recombinant 10369-H01H
IL-13/ALRH Human IL-13/ALRH Protein, Recombinant, with Native 10369-HNAC
IL-13/ALRH Mouse IL-13 / Interleukin-13 Protein, Recombinant, with Native 50225-MNAH
IL-13/ALRH Cynomolgus IL-13/ALRH Protein, Recombinant, with Native 11057-CNAH
IL-13/ALRH Cynomolgus IL-13/ALRH Protein, Recombinant 11057-C07H

Antibodies:

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human IL-13 ELISA Mouse Monoclonal Antibody 10369-MM01
Human IL-13 WB Mouse Monoclonal Antibody 10369-MM02
Human IL-13 WB, ELISA IL13 / ALRH Antibody (Antigen Affinity Purified) 10369-RP02
Human IL-13 WB, ELISA IL13 / ALRH Antibody 10369-R062
Cynomolgus IL-13 WB Rabbit Polyclonal Antibody 11057-RP02

IL13 / ALRH Antibody Background

Interleukin 13 (IL-13) is a single-chain cytokine which belongs to the IL13/IL4 family. In humans, IL13 is secreted by many cell types, but especially by T helper type 2 (Th2) cells. IL13 inhibits the production of pro-inflammatory cytokines and chemokines, and thus down-regulates macrophage activity. Meanwhile, IL-13 synergizes with IL2 in regulating IFN-gamma synthesis. IL-13 binds to a multi-subunit receptor comprising the alpha chain of the IL-4 receptor (IL-4Rα) and at least one of two known IL-13-specific binding chains (IL13 Rα1 and IL13 Rα2), and exerts its effects through signal transducer and activator of transcription 6 (STAT6), like IL-4. Accordingly, IL-13 may be critical in regulating inflammatory and immune responses as a central mediator in various cell types.

References

  1. Minty A. et al., 1993, Nature. 362: 248-50.
  2. Sironi M. et al., 1994, Blood. 84: 1913-21.
  3. Monticelli S. et al., 2004, J Biol Chem. 279: 36210-8.
  4. Solymar DC. et al., 2002, Immunity. 17: 41-50.
  5. Skinnider BF. et al., 2002, Leuk Lymphoma. 43: 1203-10.
 

 

Primary Antibody Products